A collaborative team of researchers have announced that they are one step closer to providing effective therapeutics for three neglected tropical diseases after manufacturing a chemical capable of killing the parasites that causes them.
Restoring blood-clotting ability: mouse study shows novel engineered coagulation factor could have promise for tackling anticoagulant side effects
Researchers from UT Southwestern Medical Center (Dallas, TX, USA) have identified a novel means of targeting one of the most commonly mutated genes in human cancer, a discovery with potential to treat lung cancer.
A collaborative team of researchers have demonstrated that patient-derived cancer cell lines can be used to learn how their tumors will respond to new drugs, increasing the success rate of novel cancer treatment.
Check out our double special issue exploring antibacterial drug discovery
Researchers from the Texas A&M Health Science Center College of Medicine (Round Rock, TX, USA) are developing an inhalable form of ibuprofen, which could be used to treat cystic fibrosis patients without the negative side effects associated with high doses of ibuprofen.
Researchers from Washington University (St Louis, MO, USA) have found a potential means to disrupt the spread of Zika and similar viruses in the body, research that could lead to future therapies.
Researchers from the University of Lincoln (UK) have produced pioneering synthetic derivatives of an antibiotic hailed a ‘game-changer’ in the battle against antibacterial resistance.
Small molecule drug outperforms larger molecules in combating the drug-resistance bacteria that cause skin infections in new research from the Agency for Science, Technology and Research (Singapore).
A novel hybrid molecule synthesized and developed by a team at New York University (NY, USA) shows promise as a drug delivery mechanism with potential anti-cancer applications.
Researchers from the University of Toronto Faculty of Applied Science & Engineering (Canada) have developed a novel way to grow realistic human tissue outside the body, providing a powerful new platform for drug discovery and testing, and with potential applications for eventual repair or replacement of damaged organs.
Researchers from the Walter and Eliza Hall Institute (Victoria, Australia) have discovered that the best treatment for the most deadly form of blood cancer may be to combine two recently developed drugs.
A team from the Johns Hopkins Bloomberg School of Public Health (MD, USA) has developed tiny brain-like structures, made up of human neurons and cells, with the potential to dramatically change how drugs for neurological conditions are evaluated.
Novel drug target may restore functional deficits in Rett Syndrome patients.
New compound is able to stop the formation of amyloid plaques in a transgenic mouse model for Alzheimer's disease
A deeper understanding of the host factor's function may lead to promising new ways to target HIV